ID

20524

Beschrijving

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation; ODM derived from: https://clinicaltrials.gov/show/NCT00776828

Link

https://clinicaltrials.gov/show/NCT00776828

Trefwoorden

Versies (1)
  1. 01-03-17 01-03-17 -
Geüploaded op

1 maart 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Coronary Artery Disease NCT00776828

Engels

Eligibility Coronary Artery Disease NCT00776828

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject must be at leat 18 years of age
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
Beschrijving

informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
subject must have significant coronary artery stenosis (>50% by visual estimate)
Beschrijving

Coronary Stenosis Percentage Visual estimation

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0444684
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
Beschrijving

Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis

Datatype

boolean

Alias
UMLS CUI [1,1]
C0151744
UMLS CUI [1,2]
C0340288
UMLS CUI [1,3]
C0002965
UMLS CUI [1,4]
C1275835
UMLS CUI [1,5]
C0340291
UMLS CUI [1,6]
C1141959
UMLS CUI [1,7]
C0242231
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
Beschrijving

coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C3526701
UMLS CUI [1,3]
C1262327
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
Beschrijving

Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction

Datatype

boolean

Alias
UMLS CUI [1,1]
C1532297
UMLS CUI [1,2]
C1303258
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Beschrijving

hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C2963157
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0004057
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0055729
subject who has thrombocytopenia (<120,000/ul)
Beschrijving

platelet count measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0032181
subject who has liver cirrhosis (child class b or c)
Beschrijving

liver cirrhosis

Datatype

boolean

Alias
UMLS CUI [1]
C0023890
subject who is on the anticoagulation therapy
Beschrijving

anticoagulation

Datatype

boolean

Alias
UMLS CUI [1]
C0449867
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
Beschrijving

congestive heart failure, left ventricular ejection fraction

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0428772
Terug naar het begin van de pagina

Similar models

Eligibility Coronary Artery Disease NCT00776828

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
subject must be at leat 18 years of age
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0021430 (UMLS CUI [1])
Coronary Stenosis Percentage Visual estimation
Item
subject must have significant coronary artery stenosis (>50% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0444684 (UMLS CUI [1,3])
Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis
Item
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
boolean
C0151744 (UMLS CUI [1,1])
C0340288 (UMLS CUI [1,2])
C0002965 (UMLS CUI [1,3])
C1275835 (UMLS CUI [1,4])
C0340291 (UMLS CUI [1,5])
C1141959 (UMLS CUI [1,6])
C0242231 (UMLS CUI [1,7])
coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents
Item
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
boolean
C0242231 (UMLS CUI [1,1])
C3526701 (UMLS CUI [1,2])
C1262327 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction
Item
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
boolean
C1532297 (UMLS CUI [1,1])
C1303258 (UMLS CUI [1,2])
hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Item
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
boolean
C0020517 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C2963157 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0055729 (UMLS CUI [4,2])
platelet count measurement
Item
subject who has thrombocytopenia (<120,000/ul)
boolean
C0032181 (UMLS CUI [1])
liver cirrhosis
Item
subject who has liver cirrhosis (child class b or c)
boolean
C0023890 (UMLS CUI [1])
anticoagulation
Item
subject who is on the anticoagulation therapy
boolean
C0449867 (UMLS CUI [1])
congestive heart failure, left ventricular ejection fraction
Item
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
boolean
C0018802 (UMLS CUI [1,1])
C0428772 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial